Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab
Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page
- Check2 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3. This is a minor version update and does not affect the study content or page functionality.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2, indicating a maintenance update to the ClinicalTrials.gov entry. This change does not modify study content or results.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedNew navigation/help sections were added to help users find joining information, contact details, how to read a study record, common questions, and how to join a study. The 'Intervention / Treatment' label was normalized to 'Intervention/Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.4%

- Check31 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new page build. The change does not alter the study details, eligibility, or results presented on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was deleted, reflecting an updated version tag for the record rather than substantive content changes.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.0** to **v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab
Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.